Annual CFO
-$7.24 M
-$17.89 M-167.95%
December 31, 2023
Summary
- As of March 6, 2025, OPRX annual cash flow from operations is -$7.24 million, with the most recent change of -$17.89 million (-167.95%) on December 31, 2023.
- During the last 3 years, OPRX annual CFO has fallen by -$928.80 thousand (-14.72%).
- OPRX annual CFO is now -167.95% below its all-time high of $10.65 million, reached on December 31, 2022.
Performance
OPRX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
$1.79 M
+$1.01 M+129.03%
September 30, 2024
Summary
- As of March 6, 2025, OPRX quarterly cash flow from operations is $1.79 million, with the most recent change of +$1.01 million (+129.03%) on September 30, 2024.
- Over the past year, OPRX quarterly CFO has increased by +$318.00 thousand (+21.59%).
- OPRX quarterly CFO is now -56.11% below its all-time high of $4.08 million, reached on March 31, 2022.
Performance
OPRX Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$1.57 M
+$318.00 K+16.88%
September 30, 2024
Summary
- As of March 6, 2025, OPRX TTM cash flow from operations is -$1.57 million, with the most recent change of +$318.00 thousand (+16.88%) on September 30, 2024.
- Over the past year, OPRX TTM CFO has dropped by -$3.39 million (-185.98%).
- OPRX TTM CFO is now -114.70% below its all-time high of $10.65 million, reached on December 31, 2022.
Performance
OPRX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
OPRX Cash From Operations Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -167.9% | +21.6% | -186.0% |
3 y3 years | -14.7% | +234.2% | -315.7% |
5 y5 years | -1013.4% | +219.4% | +5.7% |
OPRX Cash From Operations Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -167.9% | at low | -56.1% | +128.6% | -114.7% | +78.4% |
5 y | 5-year | -167.9% | at low | -56.1% | +128.6% | -114.7% | +78.4% |
alltime | all time | -167.9% | at low | -56.1% | +128.6% | -114.7% | +78.4% |
OptimizeRx Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $1.79 M(+129.0%) | -$1.57 M(-16.9%) |
Jun 2024 | - | $782.00 K(-63.1%) | -$1.88 M(-62.6%) |
Mar 2024 | - | $2.12 M(-133.8%) | -$5.04 M(-30.4%) |
Dec 2023 | -$7.24 M(-167.9%) | -$6.26 M(-524.8%) | -$7.24 M(-497.4%) |
Sep 2023 | - | $1.47 M(-162.2%) | $1.82 M(-52.2%) |
Jun 2023 | - | -$2.37 M(+2654.7%) | $3.81 M(-41.3%) |
Mar 2023 | - | -$86.00 K(-103.1%) | $6.49 M(-39.1%) |
Dec 2022 | $10.65 M(+1367.5%) | $2.80 M(-19.0%) | $10.65 M(+63.5%) |
Sep 2022 | - | $3.46 M(+1023.7%) | $6.52 M(+100.0%) |
Jun 2022 | - | $308.10 K(-92.4%) | $3.26 M(+3.8%) |
Mar 2022 | - | $4.08 M(-405.7%) | $3.14 M(+332.5%) |
Dec 2021 | $726.00 K(-111.5%) | -$1.33 M(-751.3%) | $726.10 K(-236.5%) |
Sep 2021 | - | $204.90 K(+7.9%) | -$532.00 K(-36.9%) |
Jun 2021 | - | $189.90 K(-88.6%) | -$843.50 K(-6.9%) |
Mar 2021 | - | $1.67 M(-164.3%) | -$905.80 K(-85.6%) |
Dec 2020 | -$6.31 M(+280.0%) | -$2.59 M(+2332.1%) | -$6.31 M(+20.9%) |
Sep 2020 | - | -$106.60 K(-183.5%) | -$5.22 M(-14.2%) |
Jun 2020 | - | $127.60 K(-103.4%) | -$6.08 M(-3.3%) |
Mar 2020 | - | -$3.74 M(+149.3%) | -$6.29 M(+278.7%) |
Dec 2019 | -$1.66 M(-309.5%) | -$1.50 M(+54.8%) | -$1.66 M(-315.2%) |
Sep 2019 | - | -$969.10 K(+1084.7%) | $771.90 K(-72.6%) |
Jun 2019 | - | -$81.80 K(-109.2%) | $2.82 M(+14.2%) |
Mar 2019 | - | $890.00 K(-4.6%) | $2.47 M(+211.6%) |
Dec 2018 | $792.60 K(-153.6%) | $932.80 K(-13.5%) | $792.60 K(-687.1%) |
Sep 2018 | - | $1.08 M(-350.0%) | -$135.00 K(-93.3%) |
Jun 2018 | - | -$431.50 K(-45.2%) | -$2.00 M(+1.7%) |
Mar 2018 | - | -$787.40 K(<-9900.0%) | -$1.97 M(+33.1%) |
Dec 2017 | -$1.48 M(+217.6%) | $5200.00(-100.7%) | -$1.48 M(-22.1%) |
Sep 2017 | - | -$788.90 K(+97.8%) | -$1.90 M(+93.0%) |
Jun 2017 | - | -$398.90 K(+34.2%) | -$984.60 K(+106.4%) |
Mar 2017 | - | -$297.20 K(-28.5%) | -$477.00 K(+2.4%) |
Dec 2016 | -$466.00 K | -$415.40 K(-427.3%) | -$465.90 K(+1891.0%) |
Sep 2016 | - | $126.90 K(+16.7%) | -$23.40 K(-125.5%) |
Jun 2016 | - | $108.70 K(-138.0%) | $91.60 K(-35.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2016 | - | -$286.10 K(-1155.7%) | $142.40 K(-72.4%) |
Dec 2015 | $515.10 K(-1014.9%) | $27.10 K(-88.8%) | $515.20 K(-32.3%) |
Sep 2015 | - | $241.90 K(+51.7%) | $760.90 K(+124.1%) |
Jun 2015 | - | $159.50 K(+84.0%) | $339.60 K(-272.9%) |
Mar 2015 | - | $86.70 K(-68.2%) | -$196.40 K(+248.2%) |
Dec 2014 | -$56.30 K(-105.0%) | $272.80 K(-252.1%) | -$56.40 K(-111.3%) |
Sep 2014 | - | -$179.40 K(-52.4%) | $500.40 K(-42.9%) |
Jun 2014 | - | -$376.50 K(-266.1%) | $876.30 K(-35.2%) |
Mar 2014 | - | $226.70 K(-72.7%) | $1.35 M(+19.4%) |
Dec 2013 | $1.13 M(-281.5%) | $829.60 K(+322.2%) | $1.13 M(+271.9%) |
Sep 2013 | - | $196.50 K(+96.7%) | $304.50 K(-314.4%) |
Jun 2013 | - | $99.90 K(+1436.9%) | -$142.00 K(-71.0%) |
Mar 2013 | - | $6500.00(+306.3%) | -$489.60 K(-21.6%) |
Dec 2012 | -$624.00 K(+19.7%) | $1600.00(-100.6%) | -$624.10 K(+15.0%) |
Sep 2012 | - | -$250.00 K(+0.9%) | -$542.80 K(-19.2%) |
Jun 2012 | - | -$247.70 K(+93.5%) | -$671.70 K(+20.4%) |
Mar 2012 | - | -$128.00 K(-254.4%) | -$557.90 K(+7.0%) |
Dec 2011 | -$521.50 K(-60.2%) | $82.90 K(-121.9%) | -$521.50 K(-12.5%) |
Sep 2011 | - | -$378.90 K(+183.0%) | -$595.70 K(-6.1%) |
Jun 2011 | - | -$133.90 K(+46.2%) | -$634.30 K(-45.4%) |
Mar 2011 | - | -$91.60 K(-1152.9%) | -$1.16 M(-11.3%) |
Dec 2010 | -$1.31 M(-25.9%) | $8700.00(-102.1%) | -$1.31 M(-17.9%) |
Sep 2010 | - | -$417.50 K(-37.0%) | -$1.60 M(+5.7%) |
Jun 2010 | - | -$662.20 K(+175.6%) | -$1.51 M(+13.6%) |
Mar 2010 | - | -$240.30 K(-13.3%) | -$1.33 M(-24.8%) |
Dec 2009 | -$1.77 M(+92.5%) | -$277.30 K(-16.4%) | -$1.77 M(-2.6%) |
Sep 2009 | - | -$331.70 K(-31.0%) | -$1.82 M(+7.3%) |
Jun 2009 | - | -$480.70 K(-29.3%) | -$1.69 M(+20.2%) |
Mar 2009 | - | -$679.90 K(+109.3%) | -$1.41 M(+53.2%) |
Dec 2008 | -$919.40 K(+202.8%) | -$324.80 K(+56.3%) | -$919.50 K(+54.6%) |
Sep 2008 | - | -$207.80 K(+6.1%) | -$594.70 K(+53.7%) |
Jun 2008 | - | -$195.80 K(+2.5%) | -$386.90 K(+102.5%) |
Mar 2008 | - | -$191.10 K | -$191.10 K |
Dec 2007 | -$303.60 K | - | - |
FAQ
- What is OptimizeRx annual cash flow from operations?
- What is the all time high annual CFO for OptimizeRx?
- What is OptimizeRx annual CFO year-on-year change?
- What is OptimizeRx quarterly cash flow from operations?
- What is the all time high quarterly CFO for OptimizeRx?
- What is OptimizeRx quarterly CFO year-on-year change?
- What is OptimizeRx TTM cash flow from operations?
- What is the all time high TTM CFO for OptimizeRx?
- What is OptimizeRx TTM CFO year-on-year change?
What is OptimizeRx annual cash flow from operations?
The current annual CFO of OPRX is -$7.24 M
What is the all time high annual CFO for OptimizeRx?
OptimizeRx all-time high annual cash flow from operations is $10.65 M
What is OptimizeRx annual CFO year-on-year change?
Over the past year, OPRX annual cash flow from operations has changed by -$17.89 M (-167.95%)
What is OptimizeRx quarterly cash flow from operations?
The current quarterly CFO of OPRX is $1.79 M
What is the all time high quarterly CFO for OptimizeRx?
OptimizeRx all-time high quarterly cash flow from operations is $4.08 M
What is OptimizeRx quarterly CFO year-on-year change?
Over the past year, OPRX quarterly cash flow from operations has changed by +$318.00 K (+21.59%)
What is OptimizeRx TTM cash flow from operations?
The current TTM CFO of OPRX is -$1.57 M
What is the all time high TTM CFO for OptimizeRx?
OptimizeRx all-time high TTM cash flow from operations is $10.65 M
What is OptimizeRx TTM CFO year-on-year change?
Over the past year, OPRX TTM cash flow from operations has changed by -$3.39 M (-185.98%)